165 related articles for article (PubMed ID: 27444613)
21. beta-adrenergic enhancement of brain kynurenic acid production mediated via cAMP-related protein kinase A signaling.
Luchowska E; Kloc R; Olajossy B; Wnuk S; Wielosz M; Owe-Larsson B; Urbanska EM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):519-29. PubMed ID: 19439240
[TBL] [Abstract][Full Text] [Related]
22. Regulation of kynurenic acid synthesis in C6 glioma cells.
Kocki T; Dolińska M; Dybel A; Urbańska EM; Turski WA; Albrecht J
J Neurosci Res; 2002 Jun; 68(5):622-6. PubMed ID: 12111852
[TBL] [Abstract][Full Text] [Related]
23. Psychopharmacological effects of acute exposure to kynurenic acid (KYNA) in zebrafish.
Robinson KS; Stewart AM; Cachat J; Landsman S; Gebhardt M; Kalueff AV
Pharmacol Biochem Behav; 2013 Jul; 108():54-60. PubMed ID: 23583441
[TBL] [Abstract][Full Text] [Related]
24. Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: Targets and anti-migraine mechanisms.
Greco R; Demartini C; Zanaboni AM; Redavide E; Pampalone S; Toldi J; Fülöp F; Blandini F; Nappi G; Sandrini G; Vécsei L; Tassorelli C
Cephalalgia; 2017 Nov; 37(13):1272-1284. PubMed ID: 27919017
[TBL] [Abstract][Full Text] [Related]
25. Cerebrolysin lowers kynurenic acid formation--an in vitro study.
Baran H; Kepplinger B
Eur Neuropsychopharmacol; 2009 Mar; 19(3):161-8. PubMed ID: 19008081
[TBL] [Abstract][Full Text] [Related]
26. Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid.
Erhardt S; Engberg G
Acta Physiol Scand; 2002 May; 175(1):45-53. PubMed ID: 11982504
[TBL] [Abstract][Full Text] [Related]
27. Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain--in vitro and ex vivo evidence.
Zielińska E; Kuc D; Zgrajka W; Turski WA; Dekundy A
Toxicol Appl Pharmacol; 2009 Oct; 240(2):174-9. PubMed ID: 19616570
[TBL] [Abstract][Full Text] [Related]
28. Strain-specific nicotinic modulation of glutamatergic transmission in the CA1 field of the rat hippocampus: August Copenhagen Irish versus Sprague-Dawley.
Alkondon M; Pereira EF; Potter MC; Kauffman FC; Schwarcz R; Albuquerque EX
J Neurophysiol; 2007 Feb; 97(2):1163-70. PubMed ID: 17151218
[TBL] [Abstract][Full Text] [Related]
29. The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction.
Klein C; Patte-Mensah C; Taleb O; Bourguignon JJ; Schmitt M; Bihel F; Maitre M; Mensah-Nyagan AG
Neuropharmacology; 2013 Jul; 70():254-60. PubMed ID: 23422298
[TBL] [Abstract][Full Text] [Related]
30. Changes of kynurenic acid content in the rat and chicken retina during ontogeny.
Rejdak R; Zarnowski T; Turski WA; Kocki T; Zagorski Z; Guenther E; Kohler K; Zrenner E
Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):687-91. PubMed ID: 12192464
[TBL] [Abstract][Full Text] [Related]
31. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
Guidetti P; Wu HQ; Schwarcz R
Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
[TBL] [Abstract][Full Text] [Related]
32. Excitatory amino acid-induced excitation of dopamine-containing neurons in the rat substantia nigra: modulation by kynurenic acid.
Wu HQ; Schwarcz R; Shepard PD
Synapse; 1994 Mar; 16(3):219-30. PubMed ID: 7515199
[TBL] [Abstract][Full Text] [Related]
33. Increased levels of kynurenic acid in brains of genetically dystonic hamsters.
Richter A; Loscher W; Baran H; Gramer M
Brain Res Dev Brain Res; 1996 Mar; 92(1):111-6. PubMed ID: 8861729
[TBL] [Abstract][Full Text] [Related]
34. [Role of glutamate receptors in the spiral ganglion neuron damage induced by acoustic noise].
Zhang YM; Ma B; Gao WY; Wen W; Liu HY
Sheng Li Xue Bao; 2007 Feb; 59(1):103-10. PubMed ID: 17294049
[TBL] [Abstract][Full Text] [Related]
35. Electrophysiological effects of exogenous and endogenous kynurenic acid in the rat brain: studies in vivo and in vitro.
Scharfman HE; Goodman JH; Schwarcz R
Amino Acids; 2000; 19(1):283-97. PubMed ID: 11026500
[TBL] [Abstract][Full Text] [Related]
36. Kynurenic acid and cancer: facts and controversies.
Walczak K; Wnorowski A; Turski WA; Plech T
Cell Mol Life Sci; 2020 Apr; 77(8):1531-1550. PubMed ID: 31659416
[TBL] [Abstract][Full Text] [Related]
37. The inimitable kynurenic acid: the roles of different ionotropic receptors in the action of kynurenic acid at a spinal level.
Tuboly G; Tar L; Bohar Z; Safrany-Fark A; Petrovszki Z; Kekesi G; Vecsei L; Pardutz A; Horvath G
Brain Res Bull; 2015 Mar; 112():52-60. PubMed ID: 25677204
[TBL] [Abstract][Full Text] [Related]
38. Indolpyruvic acid administration increases the brain content of kynurenic acid. Is this a new avenue to modulate excitatory amino acid receptors in vivo?
Russi P; Carlà V; Moroni F
Biochem Pharmacol; 1989 Aug; 38(15):2405-9. PubMed ID: 2547379
[TBL] [Abstract][Full Text] [Related]
39. Mature myelin basic protein-expressing oligodendrocytes are insensitive to kainate toxicity.
Rosenberg PA; Dai W; Gan XD; Ali S; Fu J; Back SA; Sanchez RM; Segal MM; Follett PL; Jensen FE; Volpe JJ
J Neurosci Res; 2003 Jan; 71(2):237-45. PubMed ID: 12503086
[TBL] [Abstract][Full Text] [Related]
40. Analog of kynurenic acid decreases tau pathology by modulating astrogliosis in rat model for tauopathy.
Majerova P; Olesova D; Golisova G; Buralova M; Michalicova A; Vegh J; Piestansky J; Bhide M; Hanes J; Kovac A
Biomed Pharmacother; 2022 Aug; 152():113257. PubMed ID: 35714514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
